Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children

Bone Marrow Transplantation

Volumn 29, Issue 5, 2002, Pages 383-389

  Schneider, D T ^a   Cho, J ^a   Laws, H J ^a   Dilloo, D ^a   Gobel U ^a   Nurnberger W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Children; Prognosis; Risk assessment; Scoring system; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SOLID TUMOR; TREATMENT OUTCOME; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; BLOOD DISEASE; BONE MARROW TRANSPLANTATION; HOSPITALIZATION; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 85047681843     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703384     Document Type: Article

References (28)

1. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
2. Nonmyeloablative stem cell transplantatin and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
3. Predictors of acute respiratory failure after bone marrow transplantation in children
4. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy
5. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children
6. 'Sepsis' and multi-organ failure: Predictors of poor outcome after hematopoietic stem cell transplantation in children
7. Outcome of recipients of bone marrow transplants who require intensive-care unit support
8. Admission of bone marrow transplant recipients to the intensive care unit: Outcome, survival and prognostic factors
9. The outcome of children requiring admission to an intensive care unit following bone marrow transplantation
10. Outcomes following mechanical ventilation in children undergoing bone marrow transplantation
11. Long-term survival of recipients of allogeneic bone-marrow transplantation after mechanical ventilation
12. The prognosis of oncologic patients in the pediatric intensive care unit
13. Outcome of patients requiring medical ICU admission following bone marrow transplantation
14. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines
15. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications
16. Predictors of acute respiratory failure after bone marrow transplantation in children
17. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit
18. Effect of clinical outcomes data on intensive care unit utilizatin by bone marrow transplant patients
19. Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation
20. The Pediatric Risk of Mortality III-Acute Physiology Score (PRISM III-APS): A method of assessing physiologic instability for pediatric intensive care unit patients
21. Pediatric risk of mortality (PRISM) score
22. Risk factors for capillary leakage syndrome after bone marrow transplantation
23. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Integroup study EICESS. Stem-Cell Transplant Programs at University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria
24. Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation
25. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants
26. Decision support issues using a physiology based score
27. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease
28. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation